FABP4 and atherosclerosis: Therefore, it can be speculated that FABP4 binding with FAs inhibits JAK2 signaling and decreases IL-6 levels, thus limiting the anti-atherosclerosis function and contributing to the occurrence of cardiovascular diseases.